• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Get a Second Opinion Emerges from Stealth with AI-Powered Medication Analysis Platform

by Syed Hamza Sohail 05/28/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.

– By analyzing a vast body of FDA data, clinical studies, and real-world outcomes, the company offers personalized insights that help patients make more informed decisions about prescription and over-the-counter (OTC) treatments.

Get a Second Opinion Launches AI-Driven Medication Analysis Platform to Empower Patients

The platform aims to close critical gaps in healthcare decision-making. According to the Mayo Clinic, nearly 70% of Americans take at least one prescription medication, and nearly half take two or more. Yet 76% of patients leave medical appointments confused, with 8 in 10 turning to online searches to clarify treatment options. Cost is another barrier: despite $30 billion in annual pharmaceutical marketing, almost one-third of Americans skip prescriptions due to affordability concerns.

Get a Second Opinion’s technology addresses these challenges through two key features:

·       The Discovery Tool analyzes a single medication or condition in the context of an individual’s health profile. It generates a report ranking potential options, supported by clinical data and cost comparisons—often surfacing more effective and affordable alternatives with fewer side effects.

·       The Planner reviews up to 10 medications across 10 conditions at once, identifying optimized treatment combinations while minimizing adverse interactions and redundant therapies.

According to CEO Joel Ferman, the platform empowers users to become “confident advocates” in their care by delivering insights in minutes that would traditionally take medical professionals weeks to compile.

Founded by two seasoned technology entrepreneurs with personal experience navigating the U.S. healthcare system, Get a Second Opinion was born out of frustration with opaque treatment plans and avoidable side effects. Their solution is built entirely in-house, with all data securely stored on domestic servers to ensure compliance and privacy.

By helping patients evaluate efficacy, safety, and affordability, Get a Second Opinion positions itself as a critical tool for improving health literacy and shared decision-making in an increasingly complex treatment landscape.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |